These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 33231268)

  • 1. Risk Factors and Predictors of Rebound Hyperbilirubinemia in a Term and Late-Preterm Infant with Hemolysis.
    Almohammadi H; Nasef N; Al-Harbi A; Saidy K; Nour I
    Am J Perinatol; 2022 Jun; 39(8):836-843. PubMed ID: 33231268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy.
    Chang PW; Kuzniewicz MW; McCulloch CE; Newman TB
    Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28196932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in total serum bilirubin during phototherapy in late preterm and term infants with non-haemolytic hyperbilirubinemia.
    Dani C; Becciani S; Pratesi S
    Early Hum Dev; 2019 Apr; 131():41-44. PubMed ID: 30831388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study.
    Xu C; Bao Y; He Y; Wu M; Zhu J
    J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia.
    Elhawary IM; Abdel Ghany EAG; Aboelhamed WA; Ibrahim SGE
    World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice].
    Sun G; Wang YL; Liang JF; Du LZ
    Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):848-52. PubMed ID: 18282419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound hyperbilirubinemia in term infants after phototherapy.
    Al-Saedi SA
    Saudi Med J; 2002 Nov; 23(11):1394-7. PubMed ID: 12506303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Simpler Prediction Rule for Rebound Hyperbilirubinemia.
    Chang PW; Newman TB
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31196939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates.
    Horn D; Ehret D; Gautham KS; Soll R
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013277. PubMed ID: 34228352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral agar in management of indirect hyperbilirubinemia in full-term neonates.
    Abdel-Aziz Ali SM; Mansour Galal S; Sror SM; Hussein O; Abd-El-Haseeb Ahmed AO; Hamed EA
    J Matern Fetal Neonatal Med; 2022 Mar; 35(5):975-980. PubMed ID: 32192396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Uniform intervention criteria for jaundice in hyperbilirubinemia in preterm infants].
    van Imhoff DE; Dijk PH; Hulzebos CV;
    Ned Tijdschr Geneeskd; 2009; 153():A94. PubMed ID: 19785878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hour-Specific Total Serum Bilirubin Percentiles for Infants Born at 29-35 Weeks' Gestation.
    Jegathesan T; Ray JG; Bhutani VK; Keown-Stoneman CDG; Campbell DM; Shah V; Berger H; Hayeems RZ; Sgro M;
    Neonatology; 2021; 118(6):710-719. PubMed ID: 34710869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Hyperbilirubinemia Requiring Phototherapy or Exchange Transfusion with Hearing Impairment among Admitted Term and Late Preterm Newborn in a NICU.
    Dey SK; Islam S; Jahan I; Shabuj KH; Begum S; Chisti MJ; Mannan MA; Shahidullah M; Chowdhury S
    Mymensingh Med J; 2020 Apr; 29(2):405-413. PubMed ID: 32506097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent versus continuous phototherapy for the treatment of neonatal non-hemolytic moderate hyperbilirubinemia in infants more than 34 weeks of gestational age: a randomized controlled trial.
    Sachdeva M; Murki S; Oleti TP; Kandraju H
    Eur J Pediatr; 2015 Feb; 174(2):177-81. PubMed ID: 25005717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment practices and implementation of guidelines for hyperbilirubinemia and rebound hyperbilirubinemia.
    So V; Khurshid F
    J Neonatal Perinatal Med; 2022; 15(2):335-343. PubMed ID: 34542033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Hyperbilirubinemia treatment by Locally Made Low-Cost Phototherapy Units.
    Gidi NW; Siebeck M
    Ethiop J Health Sci; 2021 Jan; 31(1):55-62. PubMed ID: 34158752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors Predicting the Need for Phototherapy in Glucose 6 Phosphate Dehydrogenase-Deficient Infants in a Large Retrospective Cohort Study.
    Gopagondanahalli KR; Mittal RA; Abdul Haium AA; Quek BH; Agarwal P; Daniel LM; Chua MC; Rajadurai VS
    Neonatology; 2022; 119(4):494-500. PubMed ID: 35700699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of intensive phototherapy in severe neonatal hyperbilirubinemia.
    Abd-Ellatif MA; Abd-Ellatif DA
    J Egypt Soc Parasitol; 2012 Aug; 42(2):483-94. PubMed ID: 23214225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice.
    Sakha SH; Gharehbaghi MM; Rahbani ME
    Indian J Med Sci; 2009 May; 63(5):174-9. PubMed ID: 19584487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Factors and Delayed TSB Monitoring and Treatment as Risk Factors Associated with Severe Hyperbilirubinemia in Term Neonates Admitted for Phototherapy.
    Boo NY; Sin S; Chee SC; Mohamed M; Ahluwalia AK; Ling MM; Ong HK
    J Trop Pediatr; 2020 Dec; 66(6):569-582. PubMed ID: 32577754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.